Ozempic, Wegovy Reduce Food Spending, New Study Finds
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
Category : Search result: obesity America
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
New Obesity Drugs Target Cell Energy Production
Scientists develop novel experimental drugs for obesity by targeting mitochondrial energy production in cells, offering a potential new treatment pathway. Learn about this breakthrough research.
Belly Fat Stiffens Heart, Risk Higher for Men: Study
A new German study reveals belly fat silently alters heart structure, raising heart disease risk, especially in men. A cardiologist explains why waist size, not just weight, is critical for Indians.
Teen's liver transplant warns of fatty liver disease risk
A 14-year-old from Surat needed a liver transplant due to advanced fatty liver disease, accelerated by junk food and genetic risk. Hepatologists urge urgent action on childhood obesity and diet.
Sleep, Stress, Belly Fat Drive India's Breast Cancer Surge
ICMR study reveals disrupted sleep, chronic stress, and central obesity are key drivers of India's rising breast cancer burden, projected to add 50,000 cases yearly. Learn the risk factors.
First Weight-Loss Pill Approved in US, Priced $149/Month
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
GLP-1 Drugs Show Benefits Beyond Weight Loss
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
Emcure Enters Obesity Market with Novo Nordisk's Semaglutide
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Why Stopping Weight-Loss Jabs Feels Like 'Jumping Off a Cliff'
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
Parents Often Overlook Their Child's Weight Issues: Study
A new study from Serbia finds most parents fail to recognise when their child is overweight, delaying crucial health interventions. Learn how to spot the signs and take action for your child's long-term wellbeing.
51% Global Population Overweight by 2035: Report
A new World Obesity Atlas warns 51% of the world will be overweight by 2035. Experts highlight higher cardiovascular risk for Asians at lower BMI. Learn about new drugs and safe weight management.
Black Cumin: A Natural Aid for Cholesterol & Weight
Discover how black cumin (kalonji), a staple in Indian kitchens, is backed by science for improving cholesterol, reducing fat cells, and supporting metabolic health. Learn easy ways to include it in your diet.
Obesity Overtakes Undernutrition in Children: UNICEF
A landmark UNICEF report reveals a historic shift: more children globally are now obese than underweight. A new scientific review links this crisis and climate change to our food systems. Discover the connection and what we can do.
Boosting India-South America Industry Partnerships: Experts
Industry leaders and diplomats call for enhanced trade and collaboration between India and South America in agriculture, tech, and energy. Discover the strategic roadmap.
Harvard Finds Gut-Liver Hub Key to Treating Diabetes, Obesity
A new Harvard study uncovers how gut microbes signal the liver to influence metabolism, offering a novel holistic approach to managing type 2 diabetes and obesity. Read the breakthrough findings.
Fast Food Culture Drives Adolescent Obesity Crisis in India
Medical experts in Bengaluru link economic growth & globalised fast food to a sharp rise in adolescent obesity, causing PCOD, diabetes & lifelong health issues. Learn the causes and solutions.
Fatty food smells in pregnancy may raise child's obesity risk
New research reveals that smells of fatty foods during pregnancy can rewire a baby's brain, increasing future risks of obesity and diabetes. Learn how to protect your child's health.
Chandigarh Study: 1 in 5 Got Diabetes in a Decade
A 10-year PGI study finds 19% of Chandigarh residents developed diabetes. Central obesity, a 1.6 cm waist increase, triples risk. Learn how to protect yourself.
Men's Snoring, Sleep Apnea & Obesity: A Critical Health Link
Loud snoring in men is often sleep apnea, a serious disorder linked to obesity. It raises risks of heart disease and diabetes. Experts urge timely diagnosis and weight management.
Childhood hypertension doubles globally, driven by obesity
A major Lancet review reveals childhood hypertension has nearly doubled since 2000, affecting 4.3% of kids. Indian experts confirm the surge, linking it to junk food, screens, and stress. Learn the signs and why screening is crucial.
Top Cooking Oils Linked to Obesity: Study
New research reveals popular cooking oils in India may contribute to obesity. Learn which oils are under scrutiny and discover healthier alternatives for your kitchen.
Early smartphone use linked to child obesity, depression: Study
A 10-year-old Mumbai boy gained 10 kg in 5 months due to smartphone addiction. A new US study confirms early smartphone use raises risks of depression, obesity, and poor sleep in children. Learn how a psychologist helped him recover.
WHO's First Guidelines on GLP-1 Drugs for Obesity
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
WHO issues first global guidelines for GLP-1 obesity drugs
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
Low Choline in Obesity Tied to Alzheimer's Risk
A new study finds low choline levels in obese young adults may be an early warning for future brain problems like Alzheimer's. Discover the vital nutrient's role and food sources to boost intake.
Fitness trainer dies from heart failure after extreme weight gain challenge
A 30-year-old Russian fitness trainer died from heart failure after consuming 10,000 calories daily. Learn the deadly risks of rapid weight gain and how to protect your heart.
Ozempic for Pets: New 'Ozempets' Trend Alarms Experts
The 'Ozempets' trend of using human weight-loss drugs like Ozempic on pets is growing. Experts warn of severe risks as these drugs are not approved for animals. Learn safe alternatives.
Dr Reddy's Wins Delhi HC Nod to Export Semaglutide
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Venezuela's Maduro Stuns with Honduras Power Play
Venezuela's Nicolas Maduro triggers regional shockwaves with a surprise political alignment in Honduras, deepening US-Latam tensions. Read the full analysis.
Page 2 of 4